Lifecore Biomedical, Inc.
LFCR
Rank in Stocks
#15832
Lifecore Biomedical, Inc., together with its subsidiaries, operates as an... Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization that serves customers in the United States, Belgium, the Netherlands, and internationally. It provides services in the development, manufacture, aseptic fill, and finish of formulations and highly viscous sterile injectable pharmaceutical drug or medical device products in syringes, vials, and cartridges in various modalities. The company also manufactures and sells pharmaceutical-grade hyaluronic acid in bulk form, as well as for use in formulated and filled syringes and vials for injectable products used in treating various medical conditions and procedures, including ophthalmic and orthopedic applications. In addition, it offers product development services, including analytical method development and validation, formulation development, sterile filtration, process scale-up, pilot studies, stability studies, process validation, and materials production for clinical studies. The company was formerly known as Landec Corporation and changed its name to Lifecore Biomedical, Inc. in November 2022. Lifecore Biomedical, Inc. was founded in 1965 and is headquartered in Chaska, Minnesota.
Share Price
$6.37
Last synced: 2026-11-09
Market Cap
$241.46M
Change (1 day)
0.16%
Change (1 year)
-17.70%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Lifecore Biomedical, Inc. (LFCR)
Category
Healthcare
EPS for Lifecore Biomedical, Inc. (LFCR)
EPS as of December 2026 TTM: $-1.10
According to Lifecore Biomedical, Inc.'s latest financial reports, its current EPS (TTM) is $-1.10. At the end of 2025 the company had an EPS of $-0.92, a decrease compared to its 2024 EPS of $0.39.
EPS history for Lifecore Biomedical, Inc. from 2000 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $-1.10 | 19.57% |
| 2025 | $-0.92 | -335.90% |
| 2024 | $0.39 | -111.75% |
| 2023 | $-3.32 | -16.37% |
| 2022 | $-3.97 | 254.46% |
| 2021 | $-1.12 | -14.50% |
| 2020 | $-1.31 | -1,851.34% |
| 2019 | $0.07 | -91.69% |
| 2018 | $0.90 | 130.77% |
| 2017 | $0.39 | -190.70% |
| 2016 | $-0.43 | -186.00% |
| 2015 | $0.50 | -29.58% |
| 2014 | $0.71 | -18.39% |
| 2013 | $0.87 | 74.00% |
| 2012 | $0.50 | 233.33% |
| 2011 | $0.15 | 0.00% |
| 2010 | $0.15 | -48.28% |
| 2009 | $0.29 | -44.23% |
| 2008 | $0.52 | -55.17% |
| 2007 | $1.16 | 231.43% |
| 2006 | $0.35 | 52.17% |
| 2005 | $0.23 | 109.09% |
| 2004 | $0.11 | -234.47% |
| 2002 | $-0.08 | -92.89% |
| 2001 | $-1.15 | 360.00% |
| 2000 | $-0.25 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $6.50 | -691.04% |
DE
|
|
| $6.08 | -652.51% |
DE
|
|
| $1.55 | -240.96% |
JP
|
|
| $3.66 | -432.73% |
CH
|
|
| $0.45 | -140.91% |
IL
|
Questions about Lifecore Biomedical, Inc.'s earnings per share (EPS)
What is Lifecore Biomedical, Inc.'s earnings per share (EPS)?
Lifecore Biomedical, Inc.'s earnings per share (EPS) over the last twelve months is $-1.10, as of Dec 2026.
What was Lifecore Biomedical, Inc.'s earnings per share (EPS) in 2025?
In 2025, Lifecore Biomedical, Inc.'s earnings per share (EPS) was $-0.92, compared with $0.39 in 2024.
How has Lifecore Biomedical, Inc.'s earnings per share (EPS) changed since 2020?
From 2020 to 2025, Lifecore Biomedical, Inc.'s earnings per share (EPS) was highest in 2024 ($0.39) and lowest in 2022 ($-3.97).
How does Lifecore Biomedical, Inc.'s earnings per share (EPS) compare with similar companies?
Lifecore Biomedical, Inc.'s earnings per share (EPS) ($-1.10) is lower than that of all 5 similar companies listed above. The highest among them is MERCK Kommanditgesellschaft auf Aktien, with $6.50.